Literature DB >> 20488955

miR-192 mediates TGF-beta/Smad3-driven renal fibrosis.

Arthur C K Chung1, Xiao R Huang, Xiaoming Meng, Hui Y Lan.   

Abstract

TGF-beta/Smad3 promotes renal fibrosis, but the mechanisms that regulate profibrotic genes remain unclear. We hypothesized that miR-192, a microRNA expressed in the kidney may mediate renal fibrosis in a Smad3-dependent manner. Microarray and real-time PCR demonstrated a tight association between upregulation of miR-192 in the fibrotic kidney and activation of TGF-beta/Smad signaling. Deletion of Smad7 promoted miR-192 expression and enhanced Smad signaling and fibrosis in obstructive kidney disease. In contrast, overexpression of Smad7 to block TGF-beta/Smad signaling inhibited miR-192 expression and renal fibrosis in the rat 5/6 nephrectomy model; in vitro, overexpression of Smad7 in tubular epithelial cells abolished TGF-beta1-induced miR-192 expression. Furthermore, Smad3 but not Smad2 mediated TGF-beta1-induced miR-192 expression by binding to the miR-192 promoter. Last, overexpression of a miR-192 mimic promoted and addition of a miR-192 inhibitor blocked TGF-beta1-induced collagen matrix expression. Taken together, miR-192 may be a critical downstream mediator of TGF-beta/Smad3 signaling in the development of renal fibrosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20488955      PMCID: PMC2938591          DOI: 10.1681/ASN.2010020134

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  37 in total

Review 1.  MicroRNA: a new frontier in kidney and blood pressure research.

Authors:  Mingyu Liang; Yong Liu; Domagoj Mladinov; Allen W Cowley; Hariprasad Trivedi; Yi Fang; Xialian Xu; Xiaoqiang Ding; Zhongmin Tian
Journal:  Am J Physiol Renal Physiol       Date:  2009-04-01

2.  Intrarenal expression of miRNAs in patients with hypertensive nephrosclerosis.

Authors:  Gang Wang; Bonnie Ching-Ha Kwan; Fernand Mac-Moune Lai; Paul Cheung-Lung Choi; Kai-Ming Chow; Philip Kam-Tao Li; Cheuk-Chun Szeto
Journal:  Am J Hypertens       Date:  2009-11-12       Impact factor: 2.689

3.  Intrarenal expression of microRNAs in patients with IgA nephropathy.

Authors:  Gang Wang; Bonnie C-H Kwan; Fernand M-M Lai; Paul C-L Choi; Kai-Ming Chow; Philip K-T Li; Cheuk-Chun Szeto
Journal:  Lab Invest       Date:  2009-11-09       Impact factor: 5.662

4.  p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest.

Authors:  Christian J Braun; Xin Zhang; Irina Savelyeva; Sonja Wolff; Ute M Moll; Troels Schepeler; Torben F Ørntoft; Claus L Andersen; Matthias Dobbelstein
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

5.  Coordinated regulation of cell cycle transcripts by p53-Inducible microRNAs, miR-192 and miR-215.

Authors:  Sara A Georges; Matthew C Biery; Soo-Yeon Kim; Janell M Schelter; Jane Guo; Aaron N Chang; Aimee L Jackson; Michael O Carleton; Peter S Linsley; Michele A Cleary; B Nelson Chau
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

6.  Advanced glycation end-products induce tubular CTGF via TGF-beta-independent Smad3 signaling.

Authors:  Arthur C K Chung; Haiyan Zhang; Yao-Zhong Kong; Jia-Ju Tan; Xiao R Huang; Jeffrey B Kopp; Hui Y Lan
Journal:  J Am Soc Nephrol       Date:  2009-12-03       Impact factor: 10.121

7.  Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy.

Authors:  Aleksandra Krupa; Robert Jenkins; Dong Dong Luo; Aled Lewis; Aled Phillips; Donald Fraser
Journal:  J Am Soc Nephrol       Date:  2010-01-07       Impact factor: 10.121

8.  Disruption of the Smad7 gene promotes renal fibrosis and inflammation in unilateral ureteral obstruction (UUO) in mice.

Authors:  Arthur C K Chung; Xiao R Huang; Li Zhou; Rainer Heuchel; Kar Neng Lai; Hui Y Lan
Journal:  Nephrol Dial Transplant       Date:  2008-12-18       Impact factor: 5.992

9.  Activation of p53 promotes renal injury in acute aristolochic acid nephropathy.

Authors:  Li Zhou; Ping Fu; Xiao R Huang; Fei Liu; Kar Neng Lai; Hui Y Lan
Journal:  J Am Soc Nephrol       Date:  2009-11-05       Impact factor: 10.121

Review 10.  The regulation of TGFbeta signal transduction.

Authors:  Aristidis Moustakas; Carl-Henrik Heldin
Journal:  Development       Date:  2009-11       Impact factor: 6.868

View more
  168 in total

1.  Managing microvascular complications of diabetes with microRNAs.

Authors:  Shawn S Badal; Farhad R Danesh
Journal:  J Am Soc Nephrol       Date:  2012-01-12       Impact factor: 10.121

2.  The long and short of microRNAs in the kidney.

Authors:  Jacqueline Ho; Jordan A Kreidberg
Journal:  J Am Soc Nephrol       Date:  2012-02-02       Impact factor: 10.121

Review 3.  Cellular and molecular mechanisms of renal fibrosis.

Authors:  Youhua Liu
Journal:  Nat Rev Nephrol       Date:  2011-10-18       Impact factor: 28.314

Review 4.  Smad-mediated regulation of microRNA biosynthesis.

Authors:  Matthew T Blahna; Akiko Hata
Journal:  FEBS Lett       Date:  2012-01-28       Impact factor: 4.124

Review 5.  Mechanisms of fibrosis: therapeutic translation for fibrotic disease.

Authors:  Thomas A Wynn; Thirumalai R Ramalingam
Journal:  Nat Med       Date:  2012-07-06       Impact factor: 53.440

Review 6.  MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets.

Authors:  Mitsuo Kato; Rama Natarajan
Journal:  Ann N Y Acad Sci       Date:  2015-04-15       Impact factor: 5.691

7.  Downregulation of microRNA-30 facilitates podocyte injury and is prevented by glucocorticoids.

Authors:  Junnan Wu; Chunxia Zheng; Yun Fan; Caihong Zeng; Zhaohong Chen; Weisong Qin; Changming Zhang; Wanfen Zhang; Xiao Wang; Xiaodong Zhu; Mingchao Zhang; Ke Zen; Zhihong Liu
Journal:  J Am Soc Nephrol       Date:  2013-09-12       Impact factor: 10.121

Review 8.  MicroRNAs as mediators and therapeutic targets in chronic kidney disease.

Authors:  Johan M Lorenzen; Hermann Haller; Thomas Thum
Journal:  Nat Rev Nephrol       Date:  2011-03-22       Impact factor: 28.314

Review 9.  MicroRNAs in mucosal inflammation.

Authors:  Viola Neudecker; Xiaoyi Yuan; Jessica L Bowser; Holger K Eltzschig
Journal:  J Mol Med (Berl)       Date:  2017-07-20       Impact factor: 4.599

Review 10.  Targeting the progression of chronic kidney disease.

Authors:  Marta Ruiz-Ortega; Sandra Rayego-Mateos; Santiago Lamas; Alberto Ortiz; Raul R Rodrigues-Diez
Journal:  Nat Rev Nephrol       Date:  2020-02-14       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.